Trial of Lixisenatide in Early Parkinson’s DiseaseWassilios G. Meissner, Olivier Rascol, Christine Brefel‐Courbon et al.|New England Journal of Medicine|2024Cited by 302
Trial of Deferiprone in Parkinson’s DiseaseDavid Devos, Christoph Scherfler, Julien Labreuche et al.|New England Journal of Medicine|2022Cited by 226
Iron as a therapeutic target for Parkinson's diseaseCaroline Moreau, James A. Duce, Olivier Rascol et al.|Movement Disorders|2018Cited by 126
AZP2006 in Progressive Supranuclear Palsy: A Multi-Centre, Randomized, Phase 2a Trial Assessing Safety and Biomarker OutcomesJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|SSRN Electronic Journal|2024Cited by 0
<scp>AZP2006</scp> in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open‐Label Extension on Safety, Biomarkers, and Disease ProgressionJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|Movement Disorders|2025Cited by 0